MICHAEL E RYTTING to Half-Life
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Half-Life.
Connection Strength
0.036
-
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. Cancer Chemother Pharmacol. 2011 Apr; 67(4):875-90.
Score: 0.022
-
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia. J Clin Pharmacol. 2004 Nov; 44(11):1309-22.
Score: 0.015